Hurley Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122K Buy
132
+1
+0.8% +$1.01K 0.07% 115
2025
Q4
$141K Buy
131
+3
+2% +$2.87K 0.08% 104
2025
Q3
$97.9K Buy
128
+14
+12% +$10.4K 0.06% 136
2025
Q2
$89K Buy
114
+11
+11% +$8.55K 0.06% 117
2025
Q1
$85.2K Sell
103
-100
-49% -$83.2K 0.06% 129
2024
Q4
$162K Buy
+203
New +$168K 0.13% 78

Other funds holding LLY

Hurley Capital's LLY Position: Q1 2026 in Review

Hurley Capital increased its Eli Lilly (LLY) stake by 0.76% in Q1 2026, buying an estimated $1.01K and bringing the position to 132 shares worth $122K. The position accounts for 0.07% of the portfolio, ranked #115.

Hurley Capital first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $162K in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hurley Capital held 132 shares of Eli Lilly worth $122K as of Q1 2026.
  • Hurley Capital bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.07% of Hurley Capital's portfolio in Q1 2026, its #115 holding.
  • Hurley Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Hurley Capital's Eli Lilly position peaked at $162K in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.